From the BMJ - The CDC pledges “To base all public health decisions on the highest quality scientific data, openly and objectively derived.” But Peter Doshi argues that in the case of influenza vaccinations and their marketing, this is not so.

Peter Doshi is a postdoctoral fellow at Johns Hopkins University School of Medicine, Baltimore, Maryland.  His report questions the motivations behind the intense push for what appears to be a failed strategy.

Read the full report from the British Medical Journal here.

 

 

Excerpt:

"This is not to say influenza vaccines have no proven benefit. Many randomized controlled trials of influenza vaccines have been conducted in the healthy adult population, and a systematic review found that, depending on vaccine-virus strain match, vaccinating between 33 and 100 people resulted in one less case of influenza.  No evidence exists, however, to show that this reduction in risk of symptomatic influenza for a specific population—here, among healthy adults—extrapolates into any reduced risk of serious complications from influenza such as hospitalizations or death in another population (complications largely occur among the frail, older population). This fact seems hard for many health commentators to grasp, who seem all too ready to take the largest statistic and apply it to all outcomes for all populations."

Share on Facebook
Share on Twitter
Please reload

Recent Posts
Please reload

Archive
Please reload

  • White Yelp Icon
  • White Google+ Icon
  • White Facebook Icon
  • White Twitter Icon

Your contact information will not be sold or shared and you may opt out of emails at any time.

©2020 by Abundant Heaven Traditional Chinese Medicine.